GlaxoSmithKline to pay $3B in health care fraud suit
WASHINGTON (KABC) -- British drug maker GlaxoSmithKline will pay an unprecedented $3 billion in fines and has agreed to plead guilty to criminal charges.
The Justice Department announced the health care fraud settlement Monday morning, making it the largest payment ever by a drug company.
The pharmaceutical giant is accused of illegally promoting the anti-depressants Paxil and Wellbutrin. Prosecutors say GlaxoSmithKline promoted uses for those drugs that were not approved.
The company is also accused of failing to report heart risks associated with its diabetes drug Avandia.
Accompanying the criminal case was a civil settlement in which the government said the company's improper marketing included providing doctors with expensive resort vacations, European hunting trips, high-paid speaking tours and even tickets to a Madonna concert.
The Associated Press contributed to this report.
fraud, legal, business
- Man high on meth terrorizes Covina family
- 4 stabbed at Fullerton bar; suspects sought
- IE pastor accused of paying boys for sex acts
- Malaysia asks countries for data to find jet
- Santa Monica building fire leaves 5 people hurt
- Santa Ana crash leaves man critically injured
- Male remains found in Gorman - investigators
- Some CA cities seek water independence
- abcnews: Delta plane loses part of wing mid-air
- Crimeans overwhelmingly vote for secession
- Chile earthquake: Magnitude-6.7 hits north coast
- Oprah to sell Harpo Studios for $32 million
- Fetching 'Peabody & Sherman' top box office
- Photos: Billboard's 25 highest-paid musicians